Articles
-
-
Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer’s disease model
-
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
-
Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants
-
Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
Aims and scope
Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Collections
Glial and Vascular Contributions to Neurodegenerative Diseases
See Molecular Neurodegeneration's ongoing Collection on Glial and Vascular Contributions to Neurodegenerative Diseases.
ALS: Challenges and New Advances
See Molecular Neurodegeneration's ongoing Collection on ALS: Challenges and New Advances.
News from Alzforum
-
-
Two New p-Tau217 Blood Tests Join a Crowded Field
01 December 2023
-
Plasma p-Tau-217 Assays Work Well, But No Home Run for Diagnosis
30 November 2023
Follow
Annual Journal Metrics
-
2022 Citation Impact
15.1 - 2-year Impact Factor
15.8 - 5-year Impact Factor
3.022 - SNIP (Source Normalized Impact per Paper)
5.158 - SJR (SCImago Journal Rank)2022 Speed
17 days submission to first editorial decision for all manuscripts (Median)
124 days submission to accept (Median)2022 Usage
1,213,867 downloads
4,511 Altmetric mentions
Contact the Managing Editorial Team
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline